It is used as a diagnostic radiopharmaceutical in oncology for the re-staging of patients with prostate cancer, the detection of locoregional recurrence of prostate cancer and the detection of bone metastases from prostate cancer. It is also used in differential diagnosis between brain metastases, gliomas, and benign brain lesions. Additionally, it is used to the imaging of hepatocellular carcinoma (HCC), both in patients at the initial diagnosis of HCC and in patients with HCC recurrence.